0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ultradian hydrocortisone replacement alters neuronal processing, emotional ambiguity, affect and fatigue in adrenal insufficiency: The PULSES trial

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Primary adrenal insufficiency (PAI) mortality and morbidity remain unacceptably high, possibly arising as glucocorticoid replacement does not replicate natural physiology. A pulsatile subcutaneous pump can closely replicate cortisol's circadian and ultradian rhythm.

          Objectives

          To assess the effect of pump therapy on quality of life, mood, functional neuroimaging, behavioural/cognitive responses, sleep and metabolism.

          Methods

          A 6‐week randomised, crossover, double‐blinded and placebo‐controlled feasibility study of usual dose hydrocortisone in PAI administered as either pulsed subcutaneous or standard care in Bristol, United Kingdom (ISRCTN67193733). Participants were stratified by adrenal insufficiency type. All participants who received study drugs are included in the analysis. The primary outcome, the facial expression recognition task (FERT), occurred at week 6.

          Results

          Between December 2014 and 2017, 22 participants were recruited – 20 completed both arms, and 21 were analysed. The pump was well‐tolerated. No change was seen in the FERT primary outcome; however, there were subjective improvements in fatigue and mood. Additionally, functional magnetic resonance imaging revealed differential neural processing to emotional cues and visual stimulation. Region of interest analysis identified the left amygdala and insula, key glucocorticoid‐sensitive regions involved in emotional ambiguity. FERT post hoc analysis confirmed this response. There were four serious adverse events (AE): three intercurrent illnesses requiring hospitalisation (1/3, 33.3% pump) and a planned procedure (1/1, 100% pump). There was a small number of expected AEs: infusion site bruising/itching (3/5, 60% pump), intercurrent illness requiring extra (3/7, 42% pump) and no extra (4/6, 66% pump) steroid.

          Conclusions

          These findings support the administration of hormone therapy that mimics physiology.

          Abstract

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research

          Despite the prevalence of sleep complaints among psychiatric patients, few questionnaires have been specifically designed to measure sleep quality in clinical populations. The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score. Clinical and clinimetric properties of the PSQI were assessed over an 18-month period with "good" sleepers (healthy subjects, n = 52) and "poor" sleepers (depressed patients, n = 54; sleep-disorder patients, n = 62). Acceptable measures of internal homogeneity, consistency (test-retest reliability), and validity were obtained. A global PSQI score greater than 5 yielded a diagnostic sensitivity of 89.6% and specificity of 86.5% (kappa = 0.75, p less than 0.001) in distinguishing good and poor sleepers. The clinimetric and clinical properties of the PSQI suggest its utility both in psychiatric clinical practice and research activities.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Development and validation of brief measures of positive and negative affect: the PANAS scales.

            In recent studies of the structure of affect, positive and negative affect have consistently emerged as two dominant and relatively independent dimensions. A number of mood scales have been created to measure these factors; however, many existing measures are inadequate, showing low reliability or poor convergent or discriminant validity. To fill the need for reliable and valid Positive Affect and Negative Affect scales that are also brief and easy to administer, we developed two 10-item mood scales that comprise the Positive and Negative Affect Schedule (PANAS). The scales are shown to be highly internally consistent, largely uncorrelated, and stable at appropriate levels over a 2-month time period. Normative data and factorial and external evidence of convergent and discriminant validity for the scales are also presented.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Short form 36 (SF36) health survey questionnaire: normative data for adults of working age.

              To gain population norms for the short form 36 health survey questionnaire (SF36) in a large community sample and to explore the questionnaire's internal consistency and validity. Postal survey by using a booklet containing the SF36 and several other items concerned with lifestyles and illness. The sample was drawn from computerised registers of the family health services authorities for Berkshire, Buckinghamshire, Northamptonshire, and Oxfordshire. 13,042 randomly selected subjects aged 18-64 years. Scores for the eight health dimensions of the SF36. The survey achieved a response rate of 72% (n = 9332). Internal consistency of the different dimensions of the questionnaire was high. Normative data broken down by age, sex, and social class were consistent with those from previous studies. The SF36 is a potentially valuable tool in medical research. The normative data provided here may further facilitate its validation and use.
                Bookmark

                Author and article information

                Contributors
                Stafford.Lightman@bristol.ac.uk
                Journal
                J Intern Med
                J Intern Med
                10.1111/(ISSN)1365-2796
                JOIM
                Journal of Internal Medicine
                John Wiley and Sons Inc. (Hoboken )
                0954-6820
                1365-2796
                19 October 2023
                January 2024
                : 295
                : 1 ( doiID: 10.1111/joim.v295.1 )
                : 51-67
                Affiliations
                [ 1 ] Laboratories of Integrative Neuroscience and Endocrinology Bristol Medical School University of Bristol Bristol UK
                [ 2 ] University Hospital Bristol and Weston NHS Foundation Trust Bristol UK
                [ 3 ] North Bristol NHS Trust Bristol UK
                [ 4 ] Department of Informatics and Telecommunications, Human‐Computer Interaction Laboratory University of Ioannina Arta Greece
                [ 5 ] Clinical Research and Imaging Centre University of Bristol Bristol UK
                [ 6 ] Faculty of Medicine and Dentistry (Malta Campus) Queen Mary University of London Victoria Malta
                [ 7 ] Department of Brain Sciences Faculty of Medicine Imperial College London London UK
                [ 8 ] Bristol Trials Centre Bristol Medical School University of Bristol Bristol UK
                [ 9 ] Neurosciences and Mental Health Liverpool Health Partners Liverpool UK
                [ 10 ] School of Psychology University of East Anglia Norwich UK
                [ 11 ] School of Medicine University of Tasmania Hobart Tasmania Australia
                [ 12 ] Division of Psychology and Language Sciences UCL London UK
                [ 13 ] Department of Psychiatry Oxford University and Oxford Health NHS Foundation Trust Oxford UK
                [ 14 ] MRC Integrative Epidemiology Unit School of Psychological Science University of Bristol Bristol UK
                Author notes
                [*] [* ] Correspondence: Stafford L. Lightman, Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, Dorothy Hodgkin Building, Whitson Street, BS1 3NY Bristol, UK.

                (Email: Stafford.Lightman@ 123456bristol.ac.uk )

                Author information
                https://orcid.org/0000-0002-1299-4116
                Article
                JOIM13721
                10.1111/joim.13721
                10952319
                37857352
                f5fe52eb-ea8d-4a12-beb0-d06a4b93cbdb
                © 2023 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Figures: 6, Tables: 3, Pages: 17, Words: 8360
                Funding
                Funded by: Medical Research Council , doi 10.13039/501100000265;
                Award ID: MR/J012548/1
                Funded by: University of Oxford , doi 10.13039/501100000769;
                Funded by: Oxford Health NIHR Biomedical Research Centre
                Funded by: University Hospitals Bristol NHS Foundation Trust , doi 10.13039/100012141;
                Funded by: Above and Beyond Charities
                Award ID: 04/2014‐15
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                January 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.9 mode:remove_FC converted:20.03.2024

                Internal medicine
                fmri,glucocorticoid replacement therapy,primary adrenal insufficiency,ultradian

                Comments

                Comment on this article